• 919 Citations
  • 13 h-Index
20062019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tiziana Pressiani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles
Hepatocellular Carcinoma Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Survival Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Leucovorin Medicine & Life Sciences
Placebos Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2019

  • 919 Citations
  • 13 h-Index
  • 20 Article
2 Citations (Scopus)

Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells

Travelli, C., Consonni, F. M., Sangaletti, S., Storto, M., Morlacchi, S., Grolla, A. A., Galli, U., Tron, G. C., Portararo, P., Rimassa, L., Pressiani, T., Mazzone, M., Trovato, R., Ugel, S., Bronte, V., Tripodo, C., Colombo, M. P., Genazzani, A. A. & Sica, A., Apr 15 2019, In : Cancer Research. 79, 8, p. 1938-1951 14 p.

Research output: Contribution to journalArticle

Nicotinamide Phosphoribosyltransferase
NAD
Neoplasms
Macrophage Colony-Stimulating Factor
Hematopoiesis

Cabozantinib in patients with advanced and progressing hepatocellular carcinoma

Abou-Alfa, G. K., Meyer, T., Cheng, A. L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B. Y., Cicin, I., Merle, P., Chen, Y. H., Park, J. W., Blanc, J. F., Bolondi, L., Klümpen, H. J., Chan, S. L., Zagonel, V., Pressiani, T., Ryu, M. H., Venook, A. P., Hessel, C., Borgman-Hagey, A. E. & 2 others, Schwab, G. & Kelley, R. K., Jul 5 2018, In : New England Journal of Medicine. 379, 1, p. 54-63 10 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Placebos
Disease-Free Survival
Survival
Disease Progression
208 Citations (Scopus)

Cabozantinib in patients with advanced and progressing hepatocellular carcinoma

Abou-Alfa, G. K., Meyer, T., Cheng, A. L., El-Khoueiry, A. B., Rimassa, L., Ryoo, B. Y., Cicin, I., Merle, P., Chen, Y. H., Park, J. W., Blanc, J. F., Bolondi, L., Klümpen, H. J., Chan, S. L., Zagonel, V., Pressiani, T., Ryu, M. H., Venook, A. P., Hessel, C., Borgman-Hagey, A. E. & 2 others, Schwab, G. & Kelley, R. K., Jul 5 2018, In : New England Journal of Medicine. 379, 1, p. 54-63 10 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Placebos
Disease-Free Survival
Survival
Disease Progression
1 Citation (Scopus)
Adjuvant Chemotherapy
Observational Studies
Comorbidity
Colorectal Neoplasms
Survival

High expression of HOXA13 correlates with poorly differentiated hepatocellular carcinomas and modulates sorafenib response in in vitro models

Quagliata, L., Quintavalle, C., Lanzafame, M., Matter, M. S., Novello, C., di Tommaso, L., Pressiani, T., Rimassa, L., Tornillo, L., Roncalli, M., Cillo, C., Pallante, P., Piscuoglio, S., Ng, C. K. & Terracciano, L. M., Jan 2018, In : Laboratory Investigation. 98, 1, p. 95-105 11 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
Hepatocytes
Liver
Long Noncoding RNA
MHC Class I Genes